Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus
Open Access
- 17 April 2013
- journal article
- review article
- Published by Springer Nature in Surgery Today
- Vol. 44 (2) , 219-226
Abstract
In recent years, various treatment options have become available for patients with hepatocellular carcinoma (HCC) according to the degree of background liver damage, tumor diameter and other factors associated with disease progression. Therapy has also shifted toward evidence-based treatment. Policies for the management of HCC with portal vein tumor thrombus, which has been considered an intractable condition, have not been established. Surgical resection was previously positioned as the treatment of choice, but the outcomes after resection alone were found to be disappointing. At present, multiple interdisciplinary treatments, combining resection with intra-arterial chemotherapy, radiotherapy, systemic chemotherapy and/or immunotherapy, are used on a trial-and-error basis since no standard regimens have been developed. Clinical trials of surgery combined with transarterial chemoembolization, hepatic arterial infusion of chemotherapy and radiation have obtained improved 5-year survival rates of 21.5–56 %. The safety of surgical resection in HCC with major portal vein tumor thrombus has improved, but the optimal type(s) and timing of auxiliary therapy to use in combination with resection remain to be defined.Keywords
This publication has 62 references indexed in Scilit:
- Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysisSurgery Today, 2011
- Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosisJournal of Gastroenterology, 2009
- Hepatocellular carcinoma with main portal vein tumor thrombusCancer, 2009
- Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablationJournal of Cancer Research and Clinical Oncology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinomaInternational Journal of Clinical Oncology, 2007
- Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombusCancer, 2005
- Hepatic arterial infusion of 5‐fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal veinJournal of Surgical Oncology, 2002
- The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstructionCancer, 1997
- Role of surgery in the treatment of primary carcinoma of the liver: A 31-year experienceBritish Journal of Surgery, 1987